Here's another scary one:

REQUIRED VIEWING! Dr. Sherri Tenpenny gives VERY important information! Hyper-immune response in test animals for previous attempts at coronavirus vaccines, like SARS and MERS, has been a persistent problem. All is well for awhile, until the animals are exposed to the wild mutated virus....





The rna vaccines - such as Pfizer type -
will destroy your immune system
Dr Sherry Tenpenny.
42 days to 1 year after the vaccine
you'll have auto immune disease.

Also on Bitchute:
https://www.bitchute.com/video/qfSMu2GT4YlO/

The use of RNA vaccines goes back to the 1990s. The in vitro demonstration of mRNA in animals was first reported in 1990,[16] and use as immunization proposed shortly thereafter.[17][18] In 1993, Martinon demonstrated that liposome-encapsulated RNA could stimulate T-cells in vivo, and in 1994, Zhou & Berglund published the first evidence that RNA could be used as a vaccine to elicit both humoral and cellular immune response against a pathogen.[3][19][20]

Hungarian biochemist Katalin Kariko attempted to solve some of the main technical barriers to introducing mRNA into cells in the 1990s. Kariko partnered with American immunologist Drew Weissman, and by 2005 they published a joint paper that solved one of the key technical barriers by using modified nucleosides to get mRNA inside cells without setting off the body's defense system.[3][21] Harvard stem cell biologist Derrick Rossi (then at Stanford) read Kariko and Weissman's paper and recognized that their work was "groundbreaking",[21] and in 2010 founded the mRNA-focused biotech Moderna along with Robert Langer, who also saw its potential in vaccine development.[21][3] Like Moderna, BioNTech also licensed Kariko and Weissman's work.[21]

In 2000, German biologist Ingmar Hoerr published an article on the efficiency of RNA‐based vaccines, which he studied as part of his doctoral degree.[22][23] After completing his PhD, he founded CureVac together with his PhD supervisor Günther Jung, Steve Pascolo, Florian von der Muelbe, and Hans-Georg Rammensee.

Up until 2020, these mRNA biotech companies had poor results testing mRNA drugs for cardiovascular, metabolic and renal diseases; selected targets for cancer; and rare diseases like Crigler–Najjar syndrome, with most finding that the side-effects of mRNA insertion were too serious.[24][25] mRNA vaccines for human use have been developed and tested for the diseases rabies, Zika, cytomegalovirus, and influenza, although these mRNA vaccines have not been licensed.[26] Many large pharmaceutical companies abandoned the technology,[24] while some biotechs re-focused on the less profitable area of vaccines, where the doses would be at lower levels and side-effects reduced.[24][27]

Before the COVID-19 pandemic, no mRNA drug or vaccine was licensed for use in humans. In December 2020, both Moderna and Pfizer/BioNTech obtained emergency use authorization for their mRNA-based COVID-19 vaccines, which had been funded by Operation Warp Speed (directly in the case of Moderna and indirectly for Pfizer/BioNTech).[21] On 2 December 2020, seven days after its final eight-week trial, the UK's Medicines and Healthcare products Regulatory Agency (MHRA), became the first global medicines regulator in history to approve an mRNA vaccine, granting "emergency authorization" for Pfizer/BioNTech's BNT162b2 COVID-19 vaccine for widespread use.[7][8][28] MHRA CEO June Raine said "no corners have been cut in approving it",[29] and that, "the benefits outweigh any risk".[30][31] On 11 December 2020 the FDA gave emergency use authorization for the Pfizer–BioNTech COVID-19 vaccine.[32].

.............  In the vernacular of vaccinology, vaccines that trigger a range of transient side effects in a lot of recipients are known as reactogenic.

All of these vaccines — in fact, most if not all the Covid-19 vaccines that have reported data so far — fall into the reactogenic category. The Advisory Committee on Immunization Practices, an expert panel that helps the Centers for Disease Control and Prevention set vaccination policies, has advised hospitals they may want to stagger vaccinations among employees  — for instance, don’t vaccinate all emergency room staff at the same time — in case some feel too unwell to work the day after being vaccinated.

The most common side effects are injection site pain, fatigue, headache, muscle pain, and joint pain. Some people in the clinical trials have reported fever. Side effects are more common after the second dose; younger adults, who have more robust immune systems, reported more side effects than older adults.


To be clear: These side effects are a sign of an immune system kicking into gear. They do not signal that the vaccine is unsafe. To date there are no serious, long-term side effects associated with receipt of these vaccines, which will be closely monitored as their use expands.

There have been reports of severe allergic reactions to the mRNA vaccines. Both the Pfizer and Moderna vaccines appear, on rare occasions, to trigger anaphylaxis, a severe and potentially life-threatening reaction. People who develop anaphylaxis must be treated with epinephrine — the drug in EpiPens — and may need to be hospitalized to ensure their airways remain open. The CDC says people should be monitored for 15 minutes after getting a Covid-19 shot, and 30 minutes if they have a history of severe allergies.

It will take time to come up with a firm estimate of how frequently this side effect occurs. The most recent data from the CDC suggest that anaphylaxis occurs at a rate of about 2.1 cases per one million doses given of the Moderna vaccine, and 6.2 cases per million doses of the Pfizer. Many of the people who have developed anaphylaxis have a history of severe allergies and some have had previous episodes of anaphylaxis.

To date the J&J vaccine has not been associated with anaphylactic reactions.        .....................

Bobby. wrote on Feb 13^th, 2021 at 11:43pm:


Yes, you should do whatever you think is best for your own health.

...........  Reactogenicity

Before vaccination, providers should counsel mRNA COVID-19 vaccine recipients about expected local (e.g., pain, swelling, erythema at the injection site, localized axillary lymphadenopathy on the same side as the vaccinated arm) and systemic (e.g., fever, fatigue, headache, chills, myalgia, arthralgia) post-vaccination symptoms. Depending on vaccine product (Pfizer vs. Moderna), age group, and vaccine dose, approximately 80–89% of vaccinated persons experience at least one local symptom and 55–83% experience at least one systemic symptom following vaccination.

Most systemic post-vaccination symptoms are mild to moderate in severity, occur within the first three days of vaccination, and resolve within 1–3 days of onset. These symptoms are more frequent and severe following the second dose and among younger persons compared with older persons (i.e., ages >55 or ≥65 years [for Pfizer-BioNTech or Moderna vaccines, respectively]). Unless persons experience a contraindication to vaccination (see below), they should be encouraged to complete the series even if they experience local or systemic symptoms following the first dose to optimize protection against COVID-19.

In clinical trials, hypersensitivity-related adverse events were observed in 0.63% of participants who received the Pfizer-BioNTech COVID-19 vaccine and 1.5% of participants who received the Moderna COVID-19 vaccine, compared with 0.51% and 1.1%, respectively, in the placebo groups. Anaphylaxis following vaccination was not observed in the Pfizer-BioNTech or Moderna COVID-19 vaccines clinical trials. However, anaphylactic reactions have been reported following receipt of mRNA vaccines outside of clinical trials.

Management of post-vaccination symptoms

Antipyretic or analgesic medications (e.g., acetaminophen, non-steroidal anti-inflammatory drugs) can be taken for the treatment of post-vaccination local or systemic symptoms, if medically appropriate. However, routine prophylactic administration of these medications for the purpose of preventing post-vaccination symptoms is not currently recommended, because information on the impact of such use on mRNA COVID-19 vaccine-induced antibody responses is not available at this time.

In addition, administration of antihistamines to COVID-19 vaccine recipients prior to vaccination to prevent allergic reactions is not recommended. Antihistamines do not prevent anaphylaxis, and their use might mask cutaneous symptoms, which could lead to a delay in the diagnosis and management of anaphylaxis. See section below (“contraindications and precautions to vaccination”) and interim considerations for anaphylaxis management for more information on management of anaphylaxis.

Infection prevention and control considerations are available for healthcare personnel and long-term care facility residents (e.g., populations included in phase 1a of vaccine allocation) with systemic signs and symptoms following COVID-19 vaccination. Considerations may be updated as additional information becomes available or additional groups are prioritized for vaccine allocation.          ..................

Sprintcyclist wrote on Feb 13^th, 2021 at 11:53pm:




It seems that auto immune diseases could result up to
7 years after you take the vaccines.

Did anyone else other than me watch the long video?

here:

[medi]https://www.youtube.com/watch?v=GziGynAo0ek[/media]